Title: Covid-19 - Provider Relief Fund
Accounting Policies: 1. Basis of PresentationThe accompanying schedule of expenditures of federal awards (the Schedule) includes federal grant activity of the University of Maryland Medical System Corporation and Subsidiaries (the Corporation) including federal awards passed through other agencies. The accompanying Schedule is presented using the accrual basis of accounting and in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). In accordance with applicable requirements, certain programs may be presented in a fiscal period based on program-specific guidance (see Note 3). Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the Corporations consolidated financial statements.The preparation of the Schedule in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts in the Schedule of expenditures of federal awards during the reporting period. Actual results could differ from those estimates.
De Minimis Rate Used: N
Rate Explanation: 2. Indirect Cost RateDirect and indirect costs are charged to awards in accordance with cost principles contained in the United States Department of Health and Human Services Cost Principles for Hospitals at 45 CFR Part 75 Appendix IX for Uniform Guidance awards. Under these cost principles, certain types of expenditures are not allowable or are limited as to reimbursement. The Uniform Guidance provides for a 10% de minimis indirect cost rate election; however, the Corporation did not make this election in the accompanying Schedule.
In accordance with the U.S. Department of Health and Human Services requirements specific to Federal Assistance Listing Number 93.498, COVID 19 Provider Relief Fund, the amount presented on the accompanying Schedule for the year ended June 30, 2022 for Federal Assistance Listing No. 93.498 relates to (i) Provider Relief Fund (PRF) payments received from July 1, 2020 through June 30, 2021 and (ii) used for PRF-eligible activity from the period January 1, 2020 through June 30, 2022. This payment receipt period and activity period and the resulting amount presented on the accompanying Schedule for the year ended June 30, 2022 reconciles to the PRF 3. COVID 19 Provider Relief Fund (continued)information reported to the Health Resources and Services Administration (HRSA) for PRF Reporting Period 2 and 3 as follows:Name of Reporting Entity for HRSA Reporting Periods 2 and 3 Reporting Entity Tax Identification Number (TIN)Type of DistributionTotal Other Provider Relief Fund Expenses ReportedTotal Lost Revenues ReportedTotal PRF Expenditures (Not Including Carryover) University of Maryland Medical System 52-1362793General/Targeted$1,346,846$306,418,546$57,762,969Upper Chesapeake Medical Center, Inc. 52-1253920Targeted7,900,0007,900,000University of Maryland St. Joseph Medical Center 35-2445106Targeted8,800,0008,800,000Chester River Hospital Center, Inc. 52-0679694Targeted5,246,8421,100,000Baltimore Washington Medical Center, Inc.52-0689917Targeted20,300,00011,293,834Dimensions Health Corporation52-1289729Targeted68,006,37159,692,988UM Charles Regional Medical Center52-0445374Targeted9,050,0009,050,000$1,346,846$425,721,759$155,599,791Health and Human Services (HHS) has indicated the PRF Funds should be reported according to reporting requirements of the HRSA PRF Reporting Portal (the Portal). Payments from HHS for PRF are assigned to Payment Received Periods (each, a Period) based upon the date each payment from the PRF was received. Each Period has a specified Period of Availability and timing of reporting requirements. Entities report into the Portal after each Periods deadline to use the funds (i.e., after the end of the Period of Availability). The Schedule includes $155,599,791 of PRF Funds received from HHS between July 1, 2020 through June 30, 2021, respectively. The PRF-eligible expenses attributable to Coronavirus Disease 2019 (COVID 19) and lost revenues incurred by the Corporation during the period of availability for PRF Reporting Periods 2 and 3 (January 1, 2020 through June 30, 2022) are in excess of the general and targeted distributions received from July 1, 2020 through June 30, 2021 and, therefore, the amounts presented in the table above and on the accompanying Schedule are limited to the amount of such distributions. The Corporation also received PRF payments subsequent to June 30, 2021, which are required to be reported in subsequent HRSA PRF Reporting Periods and, accordingly, pursuant to the requirements specific to Federal Assistance Listing Number 93.498, activity related to such payments is excluded from the accompanying Schedule.
Title: Noncash Federal Assistance
Accounting Policies: 1. Basis of PresentationThe accompanying schedule of expenditures of federal awards (the Schedule) includes federal grant activity of the University of Maryland Medical System Corporation and Subsidiaries (the Corporation) including federal awards passed through other agencies. The accompanying Schedule is presented using the accrual basis of accounting and in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). In accordance with applicable requirements, certain programs may be presented in a fiscal period based on program-specific guidance (see Note 3). Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the Corporations consolidated financial statements.The preparation of the Schedule in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts in the Schedule of expenditures of federal awards during the reporting period. Actual results could differ from those estimates.
De Minimis Rate Used: N
Rate Explanation: 2. Indirect Cost RateDirect and indirect costs are charged to awards in accordance with cost principles contained in the United States Department of Health and Human Services Cost Principles for Hospitals at 45 CFR Part 75 Appendix IX for Uniform Guidance awards. Under these cost principles, certain types of expenditures are not allowable or are limited as to reimbursement. The Uniform Guidance provides for a 10% de minimis indirect cost rate election; however, the Corporation did not make this election in the accompanying Schedule.
The Corporation did not receive any noncash Federal assistance including donated personal protective equipment for the year ended June 30, 2022.